WO2006019095A1 - 新規ウレタナーゼ遺伝子 - Google Patents
新規ウレタナーゼ遺伝子 Download PDFInfo
- Publication number
- WO2006019095A1 WO2006019095A1 PCT/JP2005/014950 JP2005014950W WO2006019095A1 WO 2006019095 A1 WO2006019095 A1 WO 2006019095A1 JP 2005014950 W JP2005014950 W JP 2005014950W WO 2006019095 A1 WO2006019095 A1 WO 2006019095A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polynucleotide
- sequence
- seq
- urethane compound
- polypeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01075—Urethanase (3.5.1.75)
Definitions
- the present invention relates to a polypeptide having a novel urethane compound decomposing activity (urethane bond degrading activity), that is, a polynucleotide encoding a novel uretanase, a uretanase encoded by the polynucleotide, and the polynucleotide described above. a a method of expressing an enzyme having a urethane compound resolution in a soaked host cell and purifying the enzyme. Furthermore, the present invention relates to a method for decomposing urethane compounds using host cells expressing a novel uretanase.
- Polyurethanes are also used in various fields because of their superior properties.
- the amount of waste is increasing year by year, causing serious environmental problems such as incinerator damage due to high combustion heat and landfill saturation.
- As measures against these wastes attention has been paid to microbial degradation and enzymatic degradation, which are low-cost and energy-saving processes. If the polyurethane can be decomposed into monomers by enzymes, it can be recovered and re-synthesized to produce a polyurethane that is exactly the same as the primary product, opening the way to recycling.
- Polyester-type polyurethane-degrading bacteria include B. bacillus amylolyticus TB-13 strain (Japanese Patent Application No. 2002-334162) and Comamonas acidovora ns TB-35 strain ( T.Nakajima—KamDe'F.Onuma'N.Kimpara and T.Nakahara.Isolation a nd characterization of a bacterium which uses polyester polyurethane as a sole carbon and nitrogen source.FEMS Microbiology Letters, Vol. 129,39-42, 1995) Force S It is known that these degrading bacteria decompose ester bonds in urethane, but hardly decompose urethane bonds.
- the present invention relates to a polynucleotide encoding a novel uretanase capable of breaking a urethane bond in a urethane compound, uretanase encoded by the polynucleotide, and uretanase to a host cell incorporating the polynucleotide. It is intended to provide a method for expressing and purifying the enzyme. Furthermore, an object of the present invention is to provide a method for decomposing a urethane compound using a host cell expressing a novel uretanase.
- the present inventors have purified uretanase produced by Rhodococcus quercus TB-60 strain and examined its properties in detail, and the uretanase is not only an aromatic type used as a raw material for polyurethane synthesis, but also an aliphatic type.
- a compound has also been found to have urethane bond cleavage activity, and a patent application has already been filed (Japanese Patent Application No. 2004-58475).
- the present invention is a polynucleotide comprising a polynucleotide encoding the uretanase or a complementary sequence thereof.
- the present invention is a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 2, or a polynucleotide comprising the complementary sequence of the nucleotide sequence of SEQ ID NO: 2.
- the present invention is also an enzyme uretanase comprising the peptide sequence shown in SEQ ID NO: 1 or a peptide sequence having a deletion, substitution, insertion or addition of one or several amino acids in the peptide sequence.
- the present invention is a method for purifying and obtaining an enzyme having the ability to decompose urethane compounds in a host cell into which the polynucleotide is incorporated.
- the present invention is a method for decomposing a urethane compound using a host cell expressing a novel uretanase.
- polypeptide having urethane compound-degrading activity and “uretanase” are used synonymously, and an enzyme capable of degrading a urethane bond in a urethane compound is used. That is.
- the “urethane compound” as used in the present specification refers to a compound having a urethane bond, and includes any molecular weight compound.
- Fig. 1 shows the cloning procedure of the uretanase gene derived from Rhodococcus quercus TB60 strain.
- FIG. 2 shows a method for extracting total DNA from the cells of Rhodococcus cusii TB60 strain.
- FIG. 3 shows PCR conditions
- FIG. 4 shows the results of nucleotide sequence analysis, showing a 4.2 kbp fragment in the obtained plasmid pURE9. The fragment indicates that it encodes the first half of the target uretanase gene.
- FIG. 5 shows the entire nucleotide sequence and deduced amino acid sequence of the uretanase gene ORF.
- FIG. 6 shows PCR conditions
- FIG. 7 shows the expression procedure using E. coli as a host.
- FIG. 8 shows SDS-PAGE of the purified enzyme.
- the obtained enzyme showed a molecular weight equivalent to that of uretanase derived from the TB60 strain.
- Fig. 9 shows the GC-MS analysis conditions and the analysis results of the degradation products in the confirmation test of urethane decomposing activity.
- the polynucleotide of the present invention is a polynucleotide that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 1, or a polynucleotide that also has a complementary sequence ability.
- the polypeptide having the amino acid sequence capability of SEQ ID NO: 1 is Rhodococcus quequee TB-60 strain (Rodococcus sequui TB-60 strain deposited with DSMZ, a German patent organism depositary institution on January 24, 2004. (DSMZ 16175)) produces uretanase.
- the polynucleotide having the nucleotide sequence of SEQ ID NO: 2, which is one embodiment of the polynucleotide of the present invention, is a genomic DNA of Rhodococcus quei strain TB-60, and an N-terminal of uretanase possessed by Rhodococcus cusii strain TB-60 Using a probe prepared based on an amino acid sequence such as an amino acid sequence, the probe was obtained through a hybridization and cloning process.
- the polynucleotide of the present invention can include the degeneracy thereof.
- Degeneracy is a phenomenon in which one amino acid can be encoded by different nucleotide codons.
- nucleotide sequence of the nucleic acid molecule encoding uretanase comprising the amino acid sequence shown in SEQ ID NO: 1 can be altered by degeneracy.
- a polynucleotide comprising the nucleotide sequence shown in SEQ ID NO: 2, shown in SEQ ID NO: 2 Under conditions highly stringent to the complementary sequence of the polynucleotide [e.g. 0.5M NaHPO, 7% sodium dodecyl sulfate (SDS), ImM EDTA, filtered at 65 ° C
- the encoded protein may also exhibit the same enzymatic activity. Accordingly, these polynucleotides are also included in the scope of the present invention as long as they have similar urease activity. According to the gene recombination technology, it is possible to artificially mutate a specific site of the basic polynucleotide without changing or improving the basic characteristics of the polynucleotide.
- a polynucleotide having a natural base sequence provided by the present invention or a polynucleotide having a base sequence different from that of the natural one, is artificially inserted, deleted, substituted, or added in the same manner.
- These polynucleotides can have the same or improved characteristics as those of the present invention, and the present invention includes such mutant polynucleotides. That is, the polynucleotide in which a part of the polynucleotide shown in SEQ ID NO: 2 in the sequence listing is inserted, deleted, substituted or added is 20 or less, preferably 10 or less in the sequence shown in SEQ ID NO: 2. More preferred is a polynucleotide having 5 or less bases substituted.
- polynucleotide and the nucleotide sequence shown in SEQ ID NO: 2 have a homology of 70% or more, preferably 80% or more, more preferably 90% or more (homology calculation is performed by, for example, BLAST (Ba sic Local Alignment Search Tool) can be done by using search;).
- BLAST Bo sic Local Alignment Search Tool
- Such a polynucleotide is also included in the scope of the present invention as long as it has a uretanase activity and encodes a polypeptide having the characteristics described above.
- a method for producing uretanase by a genetically modified cell is as follows. First, a polynucleotide molecule is inserted into a host cell and inserted into any vector capable of forming a recombinant microorganism.
- Vectors can be either RNA or DNA forces, which can be either prokaryotic or eukaryotic, typically viruses or plasmids.
- a vector can be expressed as an extrachromosomal element (eg, a plasmid) or it can be integrated into a chromosome.
- the integrated polynucleotide molecule can be under the control of a chromosomal promoter, under the control of a natural or plasmid promoter, or under a combination of several promoter controls. Single or multiple copies of the polynucleotide molecule can be integrated into the chromosome.
- the vector is then transferred into a host cell to form a recombinant cell.
- Suitable host cells for transfecting include any bacteria, fungi (eg, yeast) that can be transfected.
- Preferred host cells for use in the present invention include, but are not limited to, any microbial cell suitable for the expression of uretanase, including, for example, E. coli, Bacillus subtilis, yeast and the like.
- a recombinant cell containing uretanase can be obtained by culturing the host under culture conditions suitable for the host. Suitable culture conditions for the host are well-known to those of skill in the art.
- Separation and purification of uretanase from a host cell in which the polynucleotide sequence of the present invention is incorporated can be carried out by using a method usually used for separation / purification of protein having cellular force. Specifically, it can be carried out by using a separation / purification means usually used after disrupting the cells. Non-limiting examples of cell destruction include sonication, high-pressure homogenizer treatment, and osmotic shock. Separation and purification means may be used by appropriately combining methods such as salting out, gel filtration, and ion exchange chromatography.
- the recombinant enzyme is produced so that it has a His-tag at the C-terminus, the cultured cells are collected by centrifugation, and the periplasmic fraction is extracted by the osmotic shock method. Since the recombinant enzyme has a His-tag at the C-terminus and is V, it can be easily purified with a nickel-chelated column.
- uretanase is a polypeptide having the amino acid sequence of SEQ ID NO: 1.
- Another embodiment is a polypeptide in which a part of the amino acid of the polypeptide shown in SEQ ID NO: 1 is deleted, substituted, inserted or added, for example, in the amino acid sequence shown in SEQ ID NO: 1, 20 or less, preferably Polypeptides in which 10 or less, more preferably 5 or less amino acids are substituted may also exhibit uretanase activity. Therefore, as long as it has uretanase activity, these peptides are also included in the enzyme of the present invention.
- polypeptides are also included in the scope of the present invention as long as they have uretanase activity.
- the above uretanase is also hydrolyzed to amides and esters.
- the uretanase of the present invention also has urethane bond cleavage activity against aromatic and aliphatic compounds used in the synthesis of polyurethane.
- polyurethane is a general term for polymer compounds having a urethane bond (one NHCOO) in the molecule, and is obtained by reaction of a polyfunctional isocyanate with a hydroxyl group-containing compound.
- a polymer having groups such as amide, urea, and force rubamate, and a wide variety of branched or cross-linked polymers can be prepared by changing the functional number of hydroxyl group or isocyanate group. included.
- the uretanase of the present invention is stable in the pH range of 8-10.
- the uretanase is composed of 472 amino acids and has an estimated molecular weight of 50,699 Da.
- the present invention provides a method for decomposing a urethane compound by the action of uretanase produced by a genetically modified cell or uretanase produced by a microorganism originally having the ability to produce uretanase.
- the uretanase used in the method may be a purified enzyme, a crudely purified enzyme, or a liquid obtained by disrupting cells. Cell disruption can be performed by methods known to those skilled in the art.
- the urethane compound capable of decomposing the uretanase of the present invention may be any compound having a urethane bond in the molecular structure.
- a non-limiting example is toluene 2, 4—strong rubamic acid Examples include dibutyl ester, toluene 2,6 dicarbamic acid dibutyl ester, methylene bisphenol dicarbamic acid dibutyl ester, hexamethylene dicarbamic acid dibutyl ester, norbornene dicarbamate dibutyl ester and polyurethanes using these as synthetic raw materials.
- the number average molecular weight of polyurethane resin that can be applied in the decomposition method of the present invention is not particularly limited.
- the urethane compound to be subjected to decomposition may be encapsulated in a solution, for example, as an emulsion or in the form of a powder, or as a lump such as a film or a pellet.
- the amount of urethane compound added to the solution is preferably 0.01 to LO weight%.
- the amount of uretanase to be added may be extremely small, but is preferably 0.01% by weight or more (wet weight) with respect to the urethane compound in consideration of decomposition efficiency.
- the urethane compound to be decomposed may be one kind or plural kinds.
- the solution may be a solution obtained by adding a urethane compound to a buffer solution, but may also contain a nitrogen source, an inorganic salt, a vitamin or the like. Examples of the buffer solution include a phosphate buffer solution.
- the time required for the decomposition of the urethane compound depends on the type, composition, shape and amount of the urethane compound to be decomposed, the relative amount of uretanase to the urethane compound, pH, temperature and other various decomposition conditions. Can change.
- Confirmation of the decomposition of the urethane compound during the decomposition reaction is, for example, measurement of weight loss of the urethane compound subjected to decomposition, measurement of the amount of the remaining urethane compound by high performance liquid chromatography (HPLC), or urethane bonding. This can be confirmed by measuring the formation of a hydrolyzed diamine compound. Confirmation of the formation of the diamine compound can be carried out, for example, by using a diamine compound expected to be produced in a thin layer chromatography as a standard substance or by gas chromatography.
- Beth-Bacillus amylolyticus TB-13 strain known as an ester-bond degrading bacterium for polyester-type polyurethane (Accession No. FE RM P-19104, Japanese Patent Application No. 2002-334162) ) And Z or Comonas acid side borane TB-35, or an enzyme derived from these strains, and has urethane bond resolution
- polyurethane can be completely decomposed.
- Figure 1 shows the procedure for cloning the uretanase gene from Rhodococcus quercus TB60.
- Total DNA was extracted from the cells of Rhodococcus cusii TB60 strain cultured in a broth liquid medium at 30 ° C for 1 mm.
- the extraction method is as shown in FIG.
- Step B Amplification of uretanase gene by PCR
- N-terminal and internal amino acid sequences were determined.
- a polypeptide fragment of about 2 kDa obtained by digestion with V8 protease was used. Table 1 shows the determined N-terminal and internal amino acid sequences.
- the underline indicates an image »y", and the double underline indicates a Nhel.
- PCR was performed under the conditions shown in Fig. 3 using Nl-2 and N3R as primers and TB60 strain total DNA as a saddle type.
- the plasmid pN-TA obtained in B-2 was treated with a restriction enzyme to obtain insert DNA.
- a probe was prepared using this DNA fragment (Probe 1). Use the Gene Image Random-Prime Labeling Module (Amersham Bioscience) for probe preparation.
- the total DNA of TB60 strain was digested with Pstl, and a DNA fragment of about 4 kbp was extracted from an agarose gel.
- the extracted DNA was inserted into pUC 19 digested with Pstl and transformed into E. coli DH10B. Changed.
- colony direct PCR was performed to detect a plasmid having the target region.
- N1-2 / N3R was used as a primer at that time.
- the Pstl-Sall region (about 0.2 kbp) of PURE9 was amplified by PCR to prepare a probe (Probe 2).
- the primers SalF / PstR shown in Table 2 were used for PCR. PCR conditions were based on B-2.
- the total DNA of TB60 strain was digested with BamHI, and a DNA fragment of about 2.5 kbp was extracted from an agarose gel. The extracted DNA was inserted into pUC19 digested with BamHI, and E. coli DH10B was transformed. Using the obtained transformant as a saddle type, colony direct PCR was performed to detect a plasmid having the target region. SalF / PstR shown in Table 2 was used as a primer at that time.
- Fig. 5 shows the complete nucleotide sequence of this ORF and the deduced amino acid sequence.
- This ORF consisted of 1419 bp nucleotides and encoded 472 amino acids (estimated molecular weight 50,699 Da).
- the 20-amino acid sequence of N-terminal force (Metl-Ser20) completely matched the N-terminal amino acid sequence of purified urease.
- the amino acid sequence of Ara300-Met311 The sequence was identical to the internal amino acid sequence of the purified enzyme. From the above results, it was shown that this ORF encodes uretanase of A1 strain. Hereinafter, this ORF is called ureA.
- ureA was amplified by PCR using pUR9 and pURE41 as saddles. At that time, a primer (Ure-PET-Nde / Ure-PET-Nhe, Table 2) that can attach Ndel site at the 5 'end and Nhel site at the end was used. PCR conditions were as shown in Fig. 6 below.
- the amplified 1.4 kb fragment was extracted from an agarose gel and inserted into a pET25b (+) vector (Novagen) cut with Ndel / Nhel.
- a pET25b (+) vector Novagen
- an expression vector with a His-Tag attached to the C-terminus of UreA was constructed.
- the nucleotide sequence of the DNA inserted into the vector was analyzed and confirmed to be identical to ureA. This was called pURE-pet.
- Expression was performed by the method shown in FIG. E. coli BL21 (DE3) with pURE-pet was inoculated into 50 ml of LB medium (containing 100 g / ml Ap) and cultured at 30 ° C for 1 min. The whole amount was inoculated into 500 ml of LB medium (containing 100 ⁇ g / ml ⁇ ), and cultured at 20 ° C by rotary shaking. After 5 hours, 0.5 ml of ImM IPTG was added, and induction was performed at 20 ° C for 24 hours. The microbial cells after induction were sonicated and the supernatant obtained by centrifugation was used as a crude enzyme solution (Cell free extract).
- the crude enzyme solution obtained in F-2 was fractionated by precipitation with 40-60% saturated ammonium sulfate, and then subjected to affinity using a HiTrap Chelating HP column (capacity 1 ml, Amersham Bioscience). It was used for tea chromatography. Ni 2+ was chelated in advance, and then equilibrated with 2 OmM K-phosphate buffer (pH 7.0) containing 0.5 M NaCl. 60-200mM / 60min imidazole The enzyme was eluted with a linear gradient. The fraction having uretanase activity was collected, and then desalted and concentrated by ultrafiltration. Glycerol was added to 20% and stored at 4 ° C. SDS-PAGE of the purified enzyme is shown in FIG. This enzyme showed a molecular weight equivalent to that of urease derived from the TB60 strain.
- TDCB Toluene dicarnomate dibutyl ester
- MDCB methyl bisphenol dicarbamate dibutyl ester
- polyester-type polyurethane degrading enzymes As an enzyme capable of degrading solid polyurethane, several polyester-type polyurethane degrading enzymes have been reported. However, these enzymes are esterases, and the ester bond in polyurethane has the ability to break down. The urethane bond hardly breaks down, leaving a low molecular weight urethane compound as the final product. By allowing the uretanase of the present invention to coexist with these polyurethane degrading enzymes, complete degradation of the polyurethane becomes possible.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004237067A JP2006055005A (ja) | 2004-08-17 | 2004-08-17 | 新規ウレタナーゼ遺伝子 |
JP2004-237067 | 2004-08-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006019095A1 true WO2006019095A1 (ja) | 2006-02-23 |
Family
ID=35907482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/014950 WO2006019095A1 (ja) | 2004-08-17 | 2005-08-16 | 新規ウレタナーゼ遺伝子 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2006055005A (ja) |
WO (1) | WO2006019095A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008182986A (ja) * | 2007-01-31 | 2008-08-14 | Sumitomo Chemical Co Ltd | アミノアシラーゼ遺伝子 |
JP2013505710A (ja) * | 2009-09-25 | 2013-02-21 | ビーエーエスエフ ソシエタス・ヨーロピア | アミダーゼおよび3−アミノカルボン酸エステルを製造するためのその使用 |
WO2019243293A1 (de) | 2018-06-21 | 2019-12-26 | Covestro Deutschland Ag | Neue urethanasen für den enzymatischen abbau von polyurethanen |
WO2020064776A1 (en) * | 2018-09-24 | 2020-04-02 | Repsol S.A. | Biodegradation of polyether-based polyurethane and use thereof for the production of amino acids |
WO2021032513A1 (de) | 2019-08-16 | 2021-02-25 | Covestro Intellectual Property Gmbh & Co. Kg | Verfahren zum abbau von polyether-polyurethan |
EP4257683A1 (de) | 2022-04-08 | 2023-10-11 | Covestro Deutschland AG | Neue urethanasen für den enzymatischen abbau von polyurethanen |
WO2023194440A1 (de) | 2022-04-08 | 2023-10-12 | Covestro Deutschland Ag | Neue urethanasen für den enzymatischen abbau von polyurethanen |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004261103A (ja) * | 2003-03-03 | 2004-09-24 | Japan Science & Technology Agency | 新規ウレタン結合分解菌 |
JP2005245266A (ja) * | 2004-03-03 | 2005-09-15 | Japan Science & Technology Agency | 新規ウレタナーゼ |
-
2004
- 2004-08-17 JP JP2004237067A patent/JP2006055005A/ja active Pending
-
2005
- 2005-08-16 WO PCT/JP2005/014950 patent/WO2006019095A1/ja active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004261103A (ja) * | 2003-03-03 | 2004-09-24 | Japan Science & Technology Agency | 新規ウレタン結合分解菌 |
JP2005245266A (ja) * | 2004-03-03 | 2005-09-15 | Japan Science & Technology Agency | 新規ウレタナーゼ |
Non-Patent Citations (3)
Title |
---|
ADACHI Y. ET AL: "Urethane Ketsugo Setsudanno o Yusuru Biseibutsu no Tansaku", JAPAN SOCIETY FOR BIOSCIENCE. BIOTECHNOLOGY, AND AGROCHEMISTRY 2003 NENDO (HEISEI 15 NENDO) TAIKAI KOEN YOSHISHU, 5 March 2003 (2003-03-05), pages 234 - (3B02P15), XP002904085 * |
SHIMONO Y. ET AL: "Polyurethane no Seibutsu Bunkai Kotai Plastic Bunkai Koso no Komyo na Senryaku. (Microbial degradation of.......)", BIOSCIENCE & INDUSTRY, vol. 60, no. 3, 1 March 2002 (2002-03-01), pages 153 - 158, XP002904086 * |
SHIMONO Y. ET AL: "Rhodocossus equi A1 ga Seisansuru Urethane Ketsugo Setsudan Koso no Seisei Oyobi Shoseishitsu", JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY 2004 NENDO (HEISEI 16 NEN) TAIKAI KOEN YSHISHU, 5 March 2004 (2004-03-05), pages 238 - (3A24P09), XP002996826 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008182986A (ja) * | 2007-01-31 | 2008-08-14 | Sumitomo Chemical Co Ltd | アミノアシラーゼ遺伝子 |
JP2013505710A (ja) * | 2009-09-25 | 2013-02-21 | ビーエーエスエフ ソシエタス・ヨーロピア | アミダーゼおよび3−アミノカルボン酸エステルを製造するためのその使用 |
WO2019243293A1 (de) | 2018-06-21 | 2019-12-26 | Covestro Deutschland Ag | Neue urethanasen für den enzymatischen abbau von polyurethanen |
EP3587570A1 (de) | 2018-06-21 | 2020-01-01 | Covestro Deutschland AG | Neue urethanasen für den enzymatischen abbau von polyurethanen |
EP4151727A1 (de) * | 2018-06-21 | 2023-03-22 | Covestro Deutschland AG | Neue urethanasen für den enzymatischen abbau von polyurethanen |
WO2020064776A1 (en) * | 2018-09-24 | 2020-04-02 | Repsol S.A. | Biodegradation of polyether-based polyurethane and use thereof for the production of amino acids |
WO2021032513A1 (de) | 2019-08-16 | 2021-02-25 | Covestro Intellectual Property Gmbh & Co. Kg | Verfahren zum abbau von polyether-polyurethan |
EP4257683A1 (de) | 2022-04-08 | 2023-10-11 | Covestro Deutschland AG | Neue urethanasen für den enzymatischen abbau von polyurethanen |
WO2023194440A1 (de) | 2022-04-08 | 2023-10-12 | Covestro Deutschland Ag | Neue urethanasen für den enzymatischen abbau von polyurethanen |
Also Published As
Publication number | Publication date |
---|---|
JP2006055005A (ja) | 2006-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11525131B2 (en) | Recombinant vector constructed from an encoding gene of a nitrilase mutant, a recombinant genetic engineered strain and application thereof | |
Teather et al. | DNA sequence of a Fibrobacter succinogenes mixed-linkage beta-glucanase (1, 3-1, 4-beta-D-glucan 4-glucanohydrolase) gene | |
WO2006019095A1 (ja) | 新規ウレタナーゼ遺伝子 | |
Pieper et al. | Identification, cloning and sequence analysis of the poly (3-hydroxyalkanoic acid) synthase gene of the Gram-positive bacterium Rhodococcus ruber | |
CA2634269A1 (en) | Novel peptide-forming enzyme gene | |
TW201829447A (zh) | 變異型腈水合酶、編碼該變異型腈水合酶之核酸、含有該核酸之表現載體及轉形體、該變異型腈水合酶之製造方法、及醯胺化合物之製造方法 | |
JP2007104942A (ja) | テレフタル酸の代謝に関与する新規遺伝子 | |
CN113564171B (zh) | 一种提高多肽可溶性表达产量的方法 | |
KR100762315B1 (ko) | 푸자리시딘 생합성 효소 및 이를 코딩하는 유전자 | |
WO2006062189A1 (ja) | ニトリルヒドラターゼを発現する形質転換体 | |
Heinhorst et al. | Two copies of form I RuBisCO genes in Acidithiobacillus ferrooxidans ATCC 23270 | |
Vertes | Protein secretion systems of Corynebacterium glutamicum | |
JP4785120B2 (ja) | ハロヒドリンエポキシダーゼ活性を有するロドコッカス属細菌の形質転換体 | |
TWI321151B (ja) | ||
CA2384122A1 (en) | Cyclic depsipeptide synthetase and gene thereof, and mass production system for cyclic depsipeptide | |
CN106337057A (zh) | N-氨甲酰水解酶表达基因及其工程菌的构建 | |
JP4117646B2 (ja) | エステル結合含有プラスチック分解微生物、プラスチック分解酵素および該酵素をコードするポリヌクレオチド。 | |
JP6522524B2 (ja) | 新規β−グルコシダーゼおよび同酵素を用いる易分解性セサミノール配糖体の製造方法 | |
Sallam et al. | A multipurpose transposon-based vector system mediates protein expression in Rhodococcus erythropolis | |
CA2816217C (en) | Compositions and methods of producing enterokinase in yeast | |
JPWO2019216248A1 (ja) | ペプチド類の大環状化酵素 | |
US7776570B2 (en) | L-amino acid amide asymmetric hydrolase and DNA encoding the same | |
WO2005123921A1 (ja) | 新規グリセロール脱水素酵素、その遺伝子、及びその利用法 | |
KR101081012B1 (ko) | 클로로히드린 및 하이드록시카르복실산 에스테르 부제가수분해 효소 유전자 | |
Cheng et al. | Two Novel Thermal Stable Pectate Lyases from Dickeya dadantii DCE-01: Cloning, Expression and Characterization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |